Pbx3IMLL-AF9

Li Tang1, Meng Lu1, Yulong Du1

  • 1School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.

Cancer gene therapy
|March 20, 2025
PubMed
概括

急性髓性白血病 (AML) 的进展包括因Pbx3.3驱动的干扰素反应降低. I型干扰素治疗显示出通过诱导分化和延迟疾病来治疗MLL-AF9AML的潜力.